ПЕРСПЕКТИВА ЭЛЕКТРОННОЙ ПЦР С ТОЧКИ ЗРЕНИЯ ЦЕЛЕВОГО ВОЗДЕЙСТВИЯ СУЩЕСТВУЮЩИХ ПРЕПАРАТОВ ПРИ ЛЕЧЕНИИ ИНФЕКЦИОННЫХ ЗАБОЛЕВАНИЙ: ВОЗМОЖНАЯ СТРАТЕГИЯ

Научная статья
DOI:
https://doi.org/10.18454/jbg.2017.2.4.1
Выпуск: № 2 (4), 2017
Опубликована:
15.08.2017
PDF

Список литературы

  • Barcellos, G. B., Caceres, R. A., and de Azevedo, W. F. (2009). Structural studies of shikimate dehydrogenase from Bacillus anthracis complexed with cofactor NADP. Journal of Molecular Modeling, 15(2): 147, doi: 10.1007/s00894-008-0403-z

  • Bentley, R. and Haslam, E. (1990). The shikimate pathway—a metabolic tree with many branche. Critical Reviews in Biochemistry and Molecular Biology, 25(5): 307-384, doi: 10.3109/10409239009090615

  • Bordás, B., Kőmíves, T. and Lopata, A. (2003). Ligand‐based computer‐aided pesticide design. A review of applications of the CoMFA and CoMSIA methodologies. Pest Management Science, 59(4): 393-400, doi: 10.1002/ps.614

  • Campbell, H. and Nair, H. (2015). Child pneumonia at a time of epidemiological transition. The Lancet Global Health, 3(2): e65-e66, doi: 10.1016/S2214-109X(14)70308-0

  • Chong, C. R. and Sullivan, D. J. (2007). New uses for old drugs. Nature, 448(7154): 645-646, doi:10.1038/448645a

  • Coggins, J., Abell, C., Evans, L., Frederickson, M., Robinson, D., Roszak, A. and Lapthorn, A. (2003). Experiences with the shikimate-pathway enzymes as targets for rational drug design. Portland Press Limited, 31 (3) 548-552, doi: 10.1042/bst0310548

  • Cohen, M. L. (2000). Changing patterns of infectious disease. Nature, 406(6797): 762-767, doi:10.1038/35021206

  • Corbett, E. L., Watt, C. J., Walker, N., Maher, D., Williams, B. G., Raviglione, M. C. and Dye, C. (2003). The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Archives of Internal Medicine, 163(9): 1009-1021, doi:10.1001/archinte.163.9.1009

  • Crump, J. A., Luby, S. P. and Mintz, E. D. (2004). The global burden of typhoid fever. Bulletin of the World Health Organization, 82(5): 346-353, doi: 10.1590/S0042-96862004000500008

  • Crump, J. A. and Mintz, E. D. (2010). Global trends in typhoid and paratyphoid fever. Clinical Infectious Diseases, 50(2): 241-246, doi: 10.1086/649541

  • Dahl, E. L. and Rosenthal, P. J. (2008). Apicoplast translation, transcription and genome replication: targets for antimalarial antibiotics. Trends in Parasitology, 24(6): 279-284, doi: 10.1016/j.pt.2008.03.007

  • Debono, M. and Gordee, R. S. (1994). Antibiotics that inhibit fungal cell wall development. Annual Reviews in Microbiology, 48(1): 471-497, doi: 10.1146/annurev.mi.48.100194.002351

  • DiMaio, F., Tyka, M. D., Baker, M. L., Chiu, W. and Baker, D. (2009). Refinement of protein structures into low-resolution density maps using rosetta. Journal of Molecular Biology, 392(1): 181-190, doi:10.1016/j.jmb.2009.07.008

  • Durán, Á., Martínez, G. C. and Pastor, M. (2008). Development and validation of AMANDA, a new algorithm for selecting highly relevant regions in molecular interaction fields. Journal of Chemical Information and Modeling, 48(9): 1813-1823, doi: 10.1021/ci800037t

  • Eady, E. A. and Cove, J. H. (2003). Staphylococcal resistance revisited: community-acquired methicillin resistant Staphylococcus aureus-an emerging problem for the management of skin and soft tissue infections. Current Opinion in Infectious Diseases, 16(2): 103-124, doi: 10.1097/01.aco.0000065071.06965.ca

  • File, T. M. (2006). Clinical implications and treatment of multiresistant Streptococcus pneumoniae pneumonia. Clinical Microbiology and Infection, 12: 31-41, doi: 10.1111/j.1469-0691.2006.01395.x

  • File, T. M. (2004). Streptococcus pneumoniae and community-acquired pneumonia: a cause for concern. The American Journal of Medicine Supplements, 117(3): 39-50, doi: 10.1016/j.amjmed.2004.07.007

  • Fridkin, S. K., Hageman, J. C., Morrison, M., Sanza, L. T., Como-Sabetti, K., Jernigan, J. A., Harriman, K., Harrison, L. H., Lynfield, R. and Farley, M. M. (2005). Methicillin-resistant Staphylococcus aureus disease in three communities. New England Journal of Medicine, 352(14): 1436-1444, doi: 10.1056/NEJMoa043252

  • Hendlich, M., Rippmann, F. and Barnickel, G. (1997). LIGSITE: automatic and efficient detection of potential small molecule-binding sites in proteins. Journal of Molecular Graphics and Modelling, 15(6): 359-363, doi: 10.1016/S1093-3263(98)00002-3

  • Herrmann, K. M. (1995). The shikimate pathway: early steps in the biosynthesis of aromatic compounds. The Plant Cell, 7(7): 907, doi: 10.1105/tpc.7.7.907

  • Hess, B., Kutzner , C., Van Der Spoel, D. and Lindahl, E. (2008). GROMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation. Journal of Chemical Theory and Computation, 4(3): 435-447, doi: 10.1021/ct700301q

  • Jakinovich, A. and Sood, S. K. (2014). Pertussis: still a cause of death, seven decades into vaccination. Current Opinion in Pediatrics, 26(5): 597-604, doi: 10.1021/ct700301q

  • Jha, P., Chaloupka, F. J., Moore, J., Gajalakshmi, V., Gupta, P. C., Peck, R., Jamison, D., Breman, J., Measham, A. and Alleyne, G. (2006). Disease control priorities in developing countries. Disease Control Priorities in Developing Countries, doi: 10.2105/AJPH.81.1.15

  • Kays, M. B., Smith, D. W., Wack, M. F. and. Denys, G. A (2002). Levofloxacin treatment failure in a patient with fluoroquinolone‐resistant Streptococcus pneumoniae pneumonia. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 22(3): 395-399, doi: 10.1592/phco.22.5.395.33185

  • Kohanski, M. A., Dwyer, D. J., Hayete, B., Lawrence, C. A. and Collins, J. J. (2007). A common mechanism of cellular death induced by bactericidal antibiotics. Cell, 130(5): 797-810, doi: 10.1016/j.cell.2007.06.049

  • Laurie, A. T. and Jackson, R. M. (2005). Q-SiteFinder: an energy-based method for the prediction of protein–ligand binding sites. Bioinformatics, 21(9): 1908-1916, doi: 10.1093/bioinformatics/bti315

  • Law, V., Knox, C., Djoumbou, Y., Jewison, T., Guo, A. C., Liu, Y., Maciejewski, A., Arndt, D., Wilson, M. and Neveu, V. (2014). DrugBank 4.0: shedding new light on drug metabolism. Nucleic Acids Research, 42(D1): D1091-D1097, doi: 10.1093/nar/gkt1068

  • Lönnroth, K., Jaramillo, E., Williams, B. G., Dye, C. and Raviglione, M. (2009). Drivers of tuberculosis epidemics: the role of risk factors and social determinants. Social Science & Medicine, 68(12): 2240-2246, doi: 10.1016/j.socscimed.2009.03.041

  • Miller, L. G., Perdreau-Remington, F., Rieg, G., Mehdi, S., Perlroth, J., Bayer, A. S., Tang, A. W., Phung, T. O. and Spellberg, B. (2005). Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. New England Journal of Medicine, 352(14): 1445-1453, doi: 10.1056/NEJMoa042683

  • Misura, K. and Baker, D. (2005). Progress and challenges in high‐resolution refinement of protein structure models. Proteins: Structure, Function, and Bioinformatics, 59(1): 15-29, doi: 10.1002/prot.20376

  • Moran, G. J., Amii, R. N., Abrahamian, F. M. and Talan, D. A. (2005). Methicillin-resistant Staphylococcus aureus in community-acquired skin infections. Emerging Infectious Diseases, 11(6): 928, doi: 10.3201/eid1106.040641

  • Morris, G. M., Goodsell, D. S., Halliday, R. S., Huey, R., Hart, W. E., Belew, R. K. and Olson, A. J. (1998). Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. Journal of Computational Chemistry, 19(14): 1639-1662, doi: 10.1.1.113.6936

  • Nachega, J. B. and Chaisson, R. E. (2003). Tuberculosis drug resistance: a global threat. Clinical Infectious Diseases, 36(Supplement 1): S24-S30, doi: 10.1086/344657

  • Nettleman, M. D. (2005). Multidrug-resistant tuberculosis: news from the front. Jama, 293(22): 2788-2790, doi: 10.1001/jama.293.22.2788

  • Pang, K., Wan, Y. W., Choi, W. T., Donehower, L. A., Sun, J., Pant, D. and Liu, Z. (2014). Combinatorial therapy discovery using mixed integer linear programming. Bioinformatics, 30(10): 1456-1463, doi: 10.1093/bioinformatics/btu046

  • Phillips, J. C., Braun, R., Wang, W., Gumbart, J., Tajkhorshid, E., Villa, E., Chipot, C., Skeel, R. D., Kale, L.and Schulten, K. (2005). Scalable molecular dynamics with NAMD. Journal of Computational Chemistry, 26(16): 1781-1802, doi: 10.1002/jcc.20289

  • Pitchandi, P., Hopper, W. and Rao, R. (2013). Comprehensive database of Chorismate synthase enzyme from shikimate pathway in pathogenic bacteria. BMC Pharmacology and Toxicology, 14(1): 29, doi: 10.1186/2050- 6511-14-29

  • Raval, A., Piana, S., Eastwood, M. P., Dror, R. O. and Shaw, D. E. (2012). Refinement of protein structure homology models via long, all‐atom molecular dynamics simulations. Proteins: Structure, Function, and Bioinformatics, 80(8): 2071-2079, doi: 10.1002/prot.24098

  • Ryan, E. T. (2011). The cholera pandemic, still with us after half a century: time to rethink. PLOS Neglected Tropical Diseases, 5(1): e1003, doi: 10.1371/journal.pntd.0001003

  • Šali, A. and Blundell, T. L. (1993). Comparative protein modelling by satisfaction of spatial restraints. Journal of Molecular Biology, 234(3): 779-815, doi: 10.1006/jmbi.1993.1626

  • Sattler, C. A., MASON JR, E. O. and Kaplan, S. L. (2002). Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children. The Pediatric Ifectious Disease Journal, 21(10): 910-916, doi: 0.1097/01.inf.0000034268.59915.6f

  • Sinha, N., Chowdhury, S. and Sarkar, R. R. (2016). Structural Insight of NICD-MAML Interactions: Virtual Screening, Docking and Molecular Dynamics Study for Identification of Potential Inhibitor. Letters in Drug Design & Discovery,13(4): 301-313, doi: 10.2174/1570180812666150819003634

  • Sliwoski, G., Kothiwale, S., Meiler, J., & Lowe, E. W. (2014). Computational methods in drug discovery. Pharmacological Reviews, 66(1), 334-395, doi: 10.1124/pr.112.007336

  • Strambu, I. (1999). Therapeutic pneumothorax-an effective adjuvant method in treating multidrug-resistant tuberculosis. Pneumologia (Bucharest, Romania), 49(2): 129-136

  • Su, J., Zhang, L., Zhang, W., Choi, D. S., Wen, J., Jiang, B., Chang, C. C. and Zhou, X. (2014). Targeting the Biophysical Properties of the Myeloma Initiating Cell Niches: A Pharmaceutical Synergism Analysis Using Multi-Scale Agent-Based Modeling. PLoS ONE, 9(1): e85059, doi:10.1371/journal.pone.0085059

  • Trott, O. and Olson, A. J. (2010). AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31(2): 455-461, doi: 10.1002/jcc.21334

  • Wysowski, D. K. and Swartz, L. (2005). Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions. Archives of Internal Medicine, 165(12): 1363-1369, doi: 10.1001/archinte.165.12.1363

  • Zhang, Y. (2008). I-TASSER server for protein 3D structure prediction. BMC Bioinformatics, 9(1): 40, doi: 10.1186/1471-2105-9-40

  • Zhao, C., Zhang, H., Zhang, X., Liu, M., Hu, Z. and Fan, B. (2006). Application of support vector machine (SVM) for prediction toxic activity of different data sets. Toxicology, 217(2): 105-119, doi: 10.1016/j.tox.2005.08.019

  • Zignol, M., Hosseini, M. S., Wright, A., Weezenbeek, C. L. v., Nunn, P., Watt, C. J., Williams, B. G. and Dye, C. (2006). Global incidence of multidrug-resistant tuberculosis. The Journal of Infectious Diseases, 194(4): 479-485, doi: 10.1086/5058